Pancreatic Cancer Capan-1 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-212277) | Inquiry | Add to cart | |
| 0.5 ml(Cat-641275) | Inquiry | Add to cart | |
| 1.5 ml(Cat-641276) | Inquiry | Add to cart | |
| 8.0 ml(Cat-641280) | Inquiry | Add to cart |
Description
Product Information
Description
The Capan-1 cell line is a human pancreatic adenocarcinoma cell line that was originally derived from the primary tumor of a patient with pancreatic cancer. It is commonly used as an in vitro model for studying the pathogenesis of pancreatic cancer and for developing and testing potential treatments for the disease.
Capan-1 cells have been extensively characterized and exhibit many of the features observed in pancreatic cancer, including the ability to form tumors in vivo and the expression of various markers and genes associated with the disease. As such, the Capan-1 cell line is a valuable tool for investigating the mechanisms underlying pancreatic cancer, as well as for developing and testing new therapies. In order to facilitate in-depth research, a specific and efficient cell transfection system is essential. To this end, CD BioSciences has developed a specific transfection kit for the Capan-1 cell line.
